Onconetix, Inc. (ONCO)
0.6123
-0.02
(-3.12%)
USD |
NASDAQ |
Aug 28, 16:00
0.6113
0.00 (0.00%)
After-Hours: 20:00
Onconetix Cash from Operations (Quarterly) : -1.918M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.918M |
| March 31, 2026 | -2.122M |
| December 31, 2025 | -3.091M |
| September 30, 2025 | -3.178M |
| June 30, 2025 | -1.410M |
| March 31, 2025 | -2.000M |
| December 31, 2024 | -1.318M |
| September 30, 2024 | -1.147M |
| June 30, 2024 | -3.200M |
| March 31, 2024 | -5.232M |
| December 31, 2023 | -4.312M |
| September 30, 2023 | -3.040M |
| Date | Value |
|---|---|
| June 30, 2023 | -1.783M |
| March 31, 2023 | -4.446M |
| December 31, 2022 | -2.801M |
| September 30, 2022 | -1.829M |
| June 30, 2022 | -3.182M |
| March 31, 2022 | -0.8861M |
| December 31, 2021 | -0.6744M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -0.2565M |
| December 31, 2020 | -0.2674M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Aprea Therapeutics, Inc. | -3.206M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Anika Therapeutics, Inc. | -0.684M |
| Savara, Inc. | -29.75M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 4.168M |
| Free Cash Flow | -10.31M |
| Free Cash Flow Per Share (Quarterly) | -0.8552 |
| Free Cash Flow to Equity (Quarterly) | -1.815M |
| Free Cash Flow to Firm (Quarterly) | -1.914M |
| Free Cash Flow Yield | -2.85K% |